RenovoRx financial statements

레노보 RXNASDAQ:RNXT · Nasdaq · Healthcare · sector #17
$1.39-5.44%
2026-10-06 close

RenovoRx's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$11M.

Reported results

RenovoRx notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q